Seres Therapeutics, Inc.
MCRBCIK 0001609809 · Every Form 4 filed by insiders at this issuer.
Filings
8
Latest Mar 27, 2024
Unique insiders
8
Showing
8 of 8
Page 1
Top insiders
Most active reporters at Seres Therapeutics, Inc.
| Name | Roles | Filings |
|---|---|---|
| Arkowitz David | Officer | 1 |
| DesRosier Thomas | Officer | 1 |
| Ege David S. | Officer | 1 |
| Henn Matthew R. | Officer | 1 |
| Shaff Eric D. | OfficerDirector | 1 |
| Thorell Marella | Officer | 1 |
| Young Teresa L. | Officer | 1 |
| von Moltke Lisa | Officer | 1 |
All filings
8 Form 4 / 4-A filings, newest first
| Filed | Insider | Top transaction | Shares | Price | Value | |
|---|---|---|---|---|---|---|
| Mar 27, 2024 | Thorell Marella See Remarks | Holdings only | — | — | — | |
| Feb 16, 2024 | Arkowitz David Chief Financial Officer | S | 3,939 | $1.08 | $4,254 | |
| Feb 16, 2024 | Ege David S. See Remarks | S | 5,010 | $1.08 | $5,411 | |
| Feb 16, 2024 | von Moltke Lisa See Remarks | S | 4,400 | $1.08 | $4,752 | |
| Feb 16, 2024 | Young Teresa L. See Remarks | S | 3,374 | $1.08 | $3,644 | |
| Feb 16, 2024 | Henn Matthew R. See Remarks | S | 4,170 | $1.08 | $4,504 | |
| Feb 16, 2024 | Shaff Eric D. CEO and President · Director | S | 11,549 | $1.08 | $12,473 | |
| Feb 16, 2024 | DesRosier Thomas Chief Legal Officer and EVP | S | 3,939 | $1.08 | $4,254 |
Showing 1–8 of 8
Page 1 of 1
Real-time Form 4 intelligence. Smarter insider tracking.